secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001654954-23-001580
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics terminates HQ lease with $169,867 payment; no further obligations
--------------------------------------------------------------------------------

- Lease termination with CCP Concourse, LLC, effective Feb 8, 2023.
- Company paid $169,867.41 to Landlord to settle all claims and obligations.
- Lease originally expired June 30, 2024; company vacated premises Oct 31, 2022.
- No remaining rent or future obligations under the Lease.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495423001580/0001654954-23-001580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495423001580/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-001580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer